What's New in Preoperative Cardiac Testing

Murad Elias1, Vahé S Tateosian1, Deborah C Richman1

  • 1Department of Anesthesiology, Renaissance School of Medicine at Stony Brook University, Health Sciences Center, Level 4, 101 Nicolls Road, Stony Brook, NY 11794-8480, USA.

Anesthesiology Clinics
|January 26, 2024
PubMed

Insights

Millions of surgeries involve aging patients with comorbidities, increasing cardiovascular risk. Updated guidelines and new tests like NT-proBNP and troponin aid in preoperative cardiac evaluation and preventing perioperative myocardial injury.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Geriatric Medicine

Background:

  • Over 300 million surgeries occur globally each year.
  • Aging populations and comorbidities increase perioperative cardiovascular risk.
  • Current guidelines for preoperative cardiac evaluation were last updated in 2014.

Purpose of the Study:

  • To review current strategies for preoperative cardiac evaluation.
  • To discuss risk stratification tools for non-cardiac surgery.
  • To highlight the role of novel biomarkers in perioperative cardiac care.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of risk stratification tools.
  • Discussion of laboratory tests including NT-proBNP and troponin.

Main Results:

  • Multiple risk stratification tools exist to guide perioperative management.
  • Novel laboratory tests can assist in identifying and managing perioperative myocardial injury.
  • Updated guidelines are needed to reflect current knowledge.

Conclusions:

  • Comprehensive preoperative cardiac assessment is crucial for high-risk surgical patients.
  • Emerging biomarkers offer potential for improved diagnosis and prevention of perioperative cardiac events.
  • The integration of updated guidelines and advanced diagnostics can optimize patient outcomes.